Universität Wien
Warning! The directory is not yet complete and will be amended until the beginning of the term.

301407 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2024W)

Elective Course in Molecular Medicine

2.00 ECTS (1.00 SWS), SPL 30 - Biologie
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: English

Examination dates

Lecturers

Classes (iCal) - next class is marked with N

  • Monday 25.11. 15:00 - 17:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 28.11. 15:00 - 17:00 STB/Hörsaal A Campus Vienna Biocenter 5, 1030 Wien
    STB/Hörsaal B Campus Vienna Biocenter 5, 1030 Wien
  • Monday 02.12. 15:00 - 17:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 05.12. 15:00 - 17:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Monday 09.12. 15:00 - 17:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 12.12. 15:00 - 17:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien

Information

Aims, contents and method of the course

DNA tumour viruses play not only an import role as human pathogens causing diseases like cervical cancer but also serve as important tools to elucidate basic mechanisms of cancerogenesis. For example, the tumour suppressor protein p53 was discovered as a cellular protein of 53kDa targeted and inactivated by the large tumour antigen (LT) of the DNA tumour virus SV40. More recently, a novel anti-cancer strategy was developed based on the lytic function of DNA tumour viruses (e.g. ONYX015).
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants

Assessment and permitted materials

Written exam

Minimum requirements and assessment criteria

Maximum points: 40. Usually 4 questions, 10 points/question
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)

Examination topics

Content of the course. Lectures in English, exam in English. Questions can also be answered in German

Reading list

Course documents in Moodle. Information on the literature available on the slides in Moodle.

Association in the course directory

MMEI III, MMB IV.,MNEU V.,UF MA BU 01, UF MA BU 04

Last modified: Fr 13.12.2024 12:46